Health Dictionary Find a Doctor

Trichomoniasis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2], Aysha Anwar, M.B.B.S[3]

Overview

Laboratory tests used in the diagnosis of trichomoniasis include saline microscopy, culture, and nucleic acid amplification tests (NAATs).[1]

Laboratory Findings

Microscopy

Wet-mount microscopy: has been used as the preferred diagnostic test, however it has low sensitivity (44%–68%) compared with culture. To improve detection, clinicians using wet mounts should attempt to evaluate slides immediately after specimen collection because sensitivity decreases quickly to 20% within 1 hour after collection.[2]

Trichomoniasis is diagnosed by visually observing the trichomonads via a microscope. In women, the examiner collects the specimen during a pelvic examination by inserting a speculum into the vagina and then using a cotton-tipped applicator to collect the sample. The sample is then placed onto a microscopic slide and sent to a laboratory to be analyzed. Trichomoniasis has been difficult to diagnose due to the poor sensitivity of the tests.[3][1] [4][5]

Findings on microscopy suggestive of trichomoniasis include:[6][7]


Trichomonas vaginalis Pap smear

Two trophozoites of Trichomonas vaginalis obtained from in vitro culture. Smear was stained with Giemsa.[8]

Culture

Historically, culture has been the gold standard for diagnosis of trichomoniasis. However, sensitivity is somewhat low (70-89%).[9]

Nucleic Acid Amplification Tests

Nucleic acid probe techniques, the most sensitive tests, are moderately priced and fast, but they require instrumentation and thus are not considered point-of-care. The APTIMA Trichomonas vaginalis Assay (Hologic Gen-Probe, San Diego, CA) was FDA-cleared in 2011 for use with urine, endocervical, and vaginal swabs, and endocervical specimens collected in the Hologic PreserveCyt solution (ThinPrep) from females only. Sensitivity is 95–100% and specificity is also 95–100%.[10][11][12]

References

  1. 1.0 1.1 http://www.cdc.gov/std/tg2015/trichomoniasis.htm Accessed on September 14, 2016
  2. “Trichomoniasis – STI Treatment Guidelines”.
  3. Andrea SB, Chapin KC (2011). “Comparison of Aptima Trichomonas vaginalis Transcription-Mediated Amplification Assay and BD Affirm VPIII for Detection of T. vaginalis in Symptomatic Women: Performance Parameters and Epidemiological Implications”. J Clin Microbiol. 49 (3): 866–9. doi:10.1128/JCM.02367-10. PMID 21248097. Lay summary.
  4. Nye, Melinda B., Jane R. Schwebke, and Barbara A. Body. “Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.” American journal of obstetrics and gynecology 200.2 (2009): 188-e1.
  5. Stoner, Kevin A., et al. “Survival of Trichomonas vaginalis in wet preparation and on wet mount.” Sexually transmitted infections (2013): sextrans-2012.
  6. Hobbs MM, Seña AC (2013). “Modern diagnosis of Trichomonas vaginalis infection”. Sex Transm Infect. 89 (6): 434–8. doi:10.1136/sextrans-2013-051057. PMC 3787709. PMID 23633669.
  7. Schwebke JR, Burgess D (2004). “Trichomoniasis”. Clin Microbiol Rev. 17 (4): 794–803, table of contents. doi:10.1128/CMR.17.4.794-803.2004. PMC 523559. PMID 15489349.
  8. “DPDx – Trichomoniasis”. Retrieved 2012-12-27.
  9. Trichomoniasis . Wikipedia.https://en.wikipedia.org/wiki/Trichomoniasis Accessed on February 4, 2016
  10. Kissinger P (2015). “Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues”. BMC Infect Dis. 15: 307. doi:10.1186/s12879-015-1055-0. PMC 4525749. PMID 26242185.
  11. Nye, Melinda B., Jane R. Schwebke, and Barbara A. Body. “Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.” American journal of obstetrics and gynecology 200.2 (2009): 188-e1.
  12. Kingston, M. A., D. Bansal, and E. M. Carlin. “‘Shelf life’of Trichomonas vaginalis.” International journal of STD & AIDS 14.1 (2003): 28.


Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH